Literature DB >> 9628108

Idiopathic hypersomnia.

M Billiard1, C Merle, B Carlander, B Ondze, D Alvarez, A Besset.   

Abstract

Identification of idiopathic hypersomnia dates back 20 years only. It typically consists of prolonged nocturnal sleep, great difficulty waking up in the morning or at the end of a nap, and constant or recurrent excessive daytime sleepiness. Complete and incomplete forms are encountered. Twenty-three subjects fulfilling ICSD criteria are reported with clinical, polysomnographic and immunogenetic data. Considering differential diagnosis is an important step in the diagnosis of idiopathic hypersomnia. Idiopathic hypersomnia is much less frequent than narcolepsy. A strong genetic component is suggested by the high proportion of familial cases. No association with HLA has been evidenced to date.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9628108     DOI: 10.1111/j.1440-1819.1998.tb00987.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  10 in total

Review 1.  Narcolepsy in children: a practical guide to its diagnosis, treatment and follow-up.

Authors:  C Guilleminault; R Pelayo
Journal:  Paediatr Drugs       Date:  2000 Jan-Feb       Impact factor: 3.022

Review 2.  Central Disorders of Hypersomnolence: Focus on the Narcolepsies and Idiopathic Hypersomnia.

Authors:  Zeeshan Khan; Lynn Marie Trotti
Journal:  Chest       Date:  2015-07       Impact factor: 9.410

3.  Idiopathic hypersomnia: clinical features and response to treatment.

Authors:  Mohsin Ali; R Robert Auger; Nancy L Slocumb; Timothy I Morgenthaler
Journal:  J Clin Sleep Med       Date:  2009-12-15       Impact factor: 4.062

Review 4.  Idiopathic Hypersomnia: Historical Account, Critical Review of Current Tests and Criteria, Diagnostic Evaluation in the Absence of Biological Markers and Robust Electrophysiological Diagnostic Criteria.

Authors:  Michel Billiard; Karel Sonka
Journal:  Nat Sci Sleep       Date:  2022-02-26

5.  IgG abnormality in narcolepsy and idiopathic hypersomnia.

Authors:  Susumu Tanaka; Makoto Honda
Journal:  PLoS One       Date:  2010-03-05       Impact factor: 3.240

Review 6.  Pharmacogenetic tools for the development of target-oriented cognitive-enhancing drugs.

Authors:  José A Apud; Daniel R Weinberger
Journal:  NeuroRx       Date:  2006-01

7.  Idiopathic hypersomnia: a study of 77 cases.

Authors:  Kirstie N Anderson; Samantha Pilsworth; Linda D Sharples; Ian E Smith; John M Shneerson
Journal:  Sleep       Date:  2007-10       Impact factor: 5.849

Review 8.  Evidence-based recommendations for the assessment and management of sleep disorders in older persons.

Authors:  Harrison G Bloom; Imran Ahmed; Cathy A Alessi; Sonia Ancoli-Israel; Daniel J Buysse; Meir H Kryger; Barbara A Phillips; Michael J Thorpy; Michael V Vitiello; Phyllis C Zee
Journal:  J Am Geriatr Soc       Date:  2009-05       Impact factor: 5.562

9.  Idiopathic hypersomnia with and without long sleep time: a controlled series of 75 patients.

Authors:  Cyrille Vernet; Isabelle Arnulf
Journal:  Sleep       Date:  2009-06       Impact factor: 5.849

10.  Is Idiopathic Hypersomnia a Circadian Rhythm Disorder?

Authors:  David Landzberg; Lynn Marie Trotti
Journal:  Curr Sleep Med Rep       Date:  2019-11-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.